Researchers uncover link between eye health and dementia
Photo:
Maciej Luczniewski/NurPhoto
Researchers have uncovered a link between eye health and dementia using data and sans from the Dunedin Longitudinal Study, which could help identify the cognitive syndrome early.
University of Otago/Ōtākou Whakaihu Waka researcher, Dr Ashleigh Barrett-Young, told
Saturday Morning
changes to the blood vessels at the back of the eye could indicate someone is at greater risk of developing dementia.
Barrett-Young, co-lead author of the study and a Research Fellow in the university's Department of Psychology, told Susie Ferguson there were two categories of retinal measurements.
"We looked at the thickness of a couple of the cell layers from the retina. These are the same cells that form the optic nerve - they connect directly with the brain.
"And we also looked at the blood vessels at the back of the eye because they're closely related to the blood vessels in the brain."
She said the idea was that if there was any sign of disease in the brain, then it should also be able to be seen in the eye.
The study participants were aged 45 when the data was collected, which Barrett-Young said was usually too young to be diagnosed with dementia.
However, she said co-author of the research, Dr Aaron Reuben, created a comprehensive index of different types of dementia risk-factors including genetic, family history, smoking, physical activity, hearing impairment, blood pressure and a history of head injuries.
Reuben combined them to make a single risk score, and the retinal measurements were checked off against this, Barrett-Young said.
"So we found that both the cellular thickness' and the blood vessel measurements were associated with increased risk for developing dementia based on those risk scores, though the blood vessels did show a stronger association."
Barrett-Young said there were too types of blood vessels at the back of the eye.
"One is arterioles - you can think of them like mini-arteries," she said.
"(It's the) same as when you have heart disease or when you have atherosclerosis. There starts getting build-up in those blood vessels and so they tend to narrow so the blood isn't flowing as well."
On the other side were venuals, which were like "mini veins".
"They tend to be subject to greater inflammation which means they end up widening so that they're not working as effectively either."
The changes taken separately indicated different things but together indicated the blood vessel system was not working as well as it could.
Barrett-Young said it was difficult to know how much more at risk these factors made people, for developing dementia.
"I think we're getting slowly closer to a better answer for that."
Barrett-Young said with Alzheimer's disease and other dementias, they began a long time before any symptoms became apparent, possibly even decades before people noticed cognitive decline.
"Currently Alzheimer's disease and dementia are usually diagnosed based on cognitive tests, including memory tests, things like that.
"But part of the problem is that we all experience some age-related changes in our memory and processing speed over time and that's just completely normal.
"So it takes a while until it's clear that the cognitive decline is beyond a level that is typical of normal ageing and that might suggest that a person has Alzheimer's disease or another type of dementia.
"But that's what makes it really hard to diagnose Alzheimer's disease in the early stages when the damage is only just beginning, and when any interventions we can do, like lifestyle changes, might have the greatest impact."
Barrett-Young said the longitudinal study gave the researchers decades of history on each subject.
She believed artificial intelligence would play a part in helping to use the retina as a biomarker for determining a person's risk of dementia.
"What we're able to tell is that there are really small changes in the eye that we probably wouldn't pick up using your standard optometry or ophthalmology tests but that taking those images and being able to use artificial intelligence may be able to give you an idea of a person's risk for dementia.
"So perhaps in the future AI will be able to tell you whether you're at increased risk of developing Alzheimer's, even possibly years before you have the disease."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Techday NZ
11 hours ago
- Techday NZ
AI-scribes boost GP efficiency but raise ethics concerns in NZ care
A survey of health professionals in New Zealand has revealed that the use of AI-powered transcription tools, or AI-scribes, is becoming prevalent among general practitioners while raising several ethical, legal, and confidentiality concerns. The study led by the University of Otago, Wellington, involved 197 providers working in primary care and documented their experiences with AI-scribes during consultations. The majority of respondents were general practitioners, but the group also included nurses, nurse practitioners, rural emergency care providers, and practice managers. Findings showed that 40 per cent of those surveyed were using AI-scribes for patient note-taking. However, only 66 per cent had read the software's terms and conditions, and 59 per cent sought patient consent before using the tool during consultations. Mixed experiences The responses collected painted a nuanced picture, with users expressing both optimism and frustration. Most who used AI-scribes reported they were helpful or very helpful, while 47 per cent estimated that using the tool in every consultation could save them between 30 minutes and two hours per day. However, a significant minority indicated that these gains could be offset by the time it took to review and correct AI-generated notes. Some users described notable concerns around the accuracy, completeness, and conciseness of the notes produced. One doctor observed, "(It) missed some critical negative findings. This meant I didn't trust it." Another remarked on the frequency of errors, referred to as 'hallucinations', noting that, "the hallucination rate was quite high, and often quite subtle." Practical challenges Difficulties with understanding local accents, vocabulary, and te reo Māori were also mentioned. Some professionals described pausing the AI tool when discussing information that could identify the patient, such as names or dates of birth. The presence of AI-scribes altered the manner in which clinicians interacted with patients. More than half the respondents said the use of the tool changed the dynamic of consultations, requiring doctors to verbalise physical examination findings and thought processes so the AI could capture relevant information. One surveyed GP recalled, "Today someone said, 'I've got pain here', and pointed to the area, and so I said out loud 'oh, pain in the right upper quadrant?'" Broader implications Professor Angela Ballantyne, Lead Researcher and Bioethicist in the Department of Primary Health Care and General Practise at the University of Otago, Wellington, said the adoption of AI transcription services is taking place rapidly in primary care, even as regulations and guidelines are still being established. "They need to be vigilant about checking patient notes for accuracy. However, as many survey respondents noted, carefully checking each AI-generated clinical note eats into, and sometimes negates any time savings." Professor Ballantyne highlighted the importance of balancing the benefits of AI-scribes with patient rights and data security needs. She stated, "Most AI-scribes rely on international cloud-based platforms (often privately owned and controlled), for processing and storing data, which raises questions about where data is stored, who has access to it, and how it can be protected from cyber threats. There are also Aotearoa-specific data governance issues that need to be recognised and resolved, particularly around Māori data sovereignty." Some respondents noted that the technology allowed them to engage more directly with patients during consultations, reporting increased eye contact and more active listening time. This, they felt, improved rapport and communication. Consent and regulation National guidance on the use of AI-scribes in healthcare is still developing. The National Artificial Intelligence and Algorithm Expert Advisory Group (NAIAEAG) at Health New Zealand – Te Whatu Ora has endorsed two AI-scribe tools, Heidi Health and iMedX, after considering privacy, security, and ethical issues. Medical Council of New Zealand guidance, expected to be released later this year, is anticipated to require explicit patient consent for the use of AI transcription tools. Professor Ballantyne commented on the consent process: "Patients should be given the right to opt out of the use of AI and still access care, and adequate training and guidelines must be put in place for health providers." She said AI technology is evolving, which may help address some current ethical and practical concerns. "Coupled with appropriate training, good governance and patient consent, the future of AI scribes holds much promise."
Scoop
a day ago
- Scoop
New Report Reveals The Grim Reality Of Heart Healthcare In New Zealand
A damning new report has exposed deep flaws in New Zealand's heart healthcare system, where access to life-saving treatment often depends on luck, postcode, and ethnicity rather than clinical need. Commissioned by The Heart of Aotearoa - Kia Manawanui Trust and prepared by the University of Otago, the ' Heart disease in Aotearoa: morbidity, mortality, and service delivery' report reveals a system plagued by chronic under-resourcing, critical workforce shortages, and deadly inequities. Trust Chief Executive Ms Letitia Harding says the report lays bare a system that is failing at every level. "Heart care in New Zealand isn't just stretched - it's on the verge of collapse. "We are failing in all aspects, and it's costing New Zealanders their lives." Key findings from the report include: Life-threatening delays: Half of all heart attack patients aren't seen within internationally accepted timeframes. Alarming workforce shortage: New Zealand has only a third of the cardiologists it should have. Systemic inequality: Māori and Pacific people are hospitalised or die from heart disease more than a decade earlier, on average, than other New Zealanders. The financial burden: Heart disease costs the country's health system and economy $13.8 billion per year A postcode lottery for care: Regions with the highest death rates -Tairāwhiti, Lakes, Whanganui, and Taranaki - have the fewest cardiac specialists. The deadliest conditions: Heart disease accounts for 20% of all deaths in New Zealand. The five heart conditions responsible for the majority are: heart failure, atrial fibrillation and flutter (AFF), acute myocardial infarction (AMI), subsequent myocardial infarction and cardiomyopathy. Trust Medical Director Dr Sarah Fairley, who is also a Wellington-based cardiologist, says the findings match what frontline clinicians see every day. "From inside the system, I can tell you that this report reflects what we see every day: a workforce stretched beyond safe limits, patients slipping through the cracks, and no end in sight." Ms Harding says this report should be a wake-up call for the Government. The Heart of Aotearoa - Kia Manawanui Trust is calling for an urgent government response, including immediate investment in public hospital cardiac care infrastructure - beds and equipment - and a national strategy to recruit and retain cardiology staff.
Otago Daily Times
a day ago
- Otago Daily Times
NZ's failing heart care 'on the verge of collapse'
New Zealand has only a third of the cardiologists it should have. Half of all heart attack patients are not being treated within accepted timeframes in New Zealand, which has just a third of the cardiologists it needs, according to a new University of Otago report commissioned by cardiac advocacy charity Kia Manawanui Trust. For the first time, the total cost of heart disease to the New Zealand economy has been calculated at an estimated $13.8 billion a year. Trust chief executive Letitia Harding said the findings exposed a system that was failing at every level. "Heart care in New Zealand isn't just stretched - it's on the verge of collapse," she said. "We are failing in all aspects and it's costing New Zealanders their lives." Key findings from the Heart disease in Aotearoa: morbidity, mortality and service delivery report include: Life-threatening delays: Half of all heart-attack patients are not seen within internationally accepted timeframes Workforce shortage: New Zealand has only a third of the cardiologists it should have Māori and Pacific people hospitalised or die from heart disease more than a decade earlier, on average, than other New Zealanders Heart disease costs the country's health system and economy $13.8 billion per year Postcode lottery for care: Regions with the highest death rates - Tairāwhitii, Lakes, Whanganui, and Taranaki - have the fewest cardiac specialists Lucy Telfar-Barnard. Photo: University of Otago Wellington-based cardiologist and trust medical director Dr Sarah Fairley said the findings by Otago researcher Dr Lucy Telfar-Barnard matched the experience of front-line clinicians. "From inside the system, I can tell you that this report reflects what we see every day - a workforce stretched beyond safe limits, patients slipping through the cracks and no end in sight." Harding said the report should be "a wake-up call for the government". The trust is calling for immediate investment in public hospital cardiac care infrastructure - beds and equipment - and a national strategy to recruit and retain cardiology staff. The total cost of heart disease deaths in 2020 was $13.09b, from 74,708 life years lost. In 2024, New Zealand had 173.2 full-time cardiologists or 32.8 FTE per million people. That is three times lower than the average (95 specialists per million) of all countries measured by the European Society of Cardiology. Ministry data showed no cardiac staff at all in Wairarapa or Whanganui, no cardiologists or sonographers/cardiac physiologists in Lakes, West Coast or Souther Canterbury, and no cardiologists in Tairāwhiti. With 96.3 full-time cardiologists per million, Auckland was the only city with comparable number of specialists to European countries. Waikato (47.5 FTE per million) was half the European average, while others were much less, ranging from 21.4 to 27. The number of cardiology sonographers had dropped from 70.4 in 2013 to just 43.5 in 2024, despite the 17% population increase. The ratio of sonographers had nearly halved from 16 per million to 8.2. Heart disease was responsible for one in five deaths and five percent of hospital admissions. The cost of heart disease: Hospitalisations cost an estimated $538,790,541 a year Work days lost $17,996,766 GP visits $65,166,640 Prescriptions $61,906,660 Mortality $13,094,819,487 Total: $13,778,680,094 These were minimum costs, as they did not include the cost of emergency department visits, nor indirect costs of workdays lost to emergency department and outpatient visits, nor years lost to disability. In a statement, Health Minister Simeon Brown said the government expected Health New Zealand to have a continued focus on strengthening cardiac services nationwide. He said the report highlighted several key areas Health New Zealand must act on, including addressing regional variations in service quality and patient outcomes. "I have been advised that Health New Zealand has established a National Clinical Cardiac Network which is developing national standards and models of care, while also establishing dedicated work streams to ensure consistent, quality care. "This includes funding for new training positions for cardiac sonographers - a key workforce needed to bring down the echocardiogram waitlist."
